{"nct_id":"NCT05501886","title":"Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2022-12-08","start_date_type":"ACTUAL","primary_completion_date":"2025-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["CELC"]}